Please visit our MS learning channel on YouTube, which provides hundreds of MS related topics from many of our video recorded education programs and archived here: -- Be empowered with MS views and news. Opt-in with us:

~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.


Thursday, February 11, 2016

MS Study Finds Lipid Antibodies Reflect Changes in Brain Volume and Lesions

MS Study Finds Lipid Antibodies Reflect Changes in Brain Volume and Lesions

FEBRUARY 10, 2016

Brigham and Women’s Hospital researchers reported that antibodies directed at lipids are associated with magnetic resonance imaging (MRI) measures of brain degeneration in patients with multiple sclerosis (MS), and may potentially serve as biomarkers for monitoring disease status.
While the hyperintense brain lesions detected by MRI are crucial for diagnosis and therapeutic monitoring, they have proven to be of little value in predicting disease progression. Measurements of brain atrophy might associate better with clinical status. Earlier studies have shown that atrophy in the brain’s gray matter is more closely linked to disease status than atrophy in its white matter, and that compartment-specific measures need to be used when analyzing disease progression.
In the study Serum lipid antibodies are associated with cerebral tissue damage in multiple sclerosis, researchers explored the possible relationships between immune factors, measured by an antigen array, and brain changes measured by MRI.

The research team, led by Rohit Bakshi, recruited 21 patients with relapsing-remitting MS (RRMS), and measured 420 different antigens present in serum samples taken from them. The patients also underwent MRI scans to assess the gray matter and white matter regions, as well as total brain tissue volume. Finally, researchers investigated lesion load based on the MRI scans.

MS Views and News 
helps to provide educational information for persons affected by MS
Keep current with Multiple Sclerosis news and information 
by opting-in to our website: click here - thank you

No comments: